Search results
Results From The WOW.Com Content Network
ICD-9-CM: Volumes 1 and 2 only. Volume 3 contains Procedure codes: ICD-10: The international standard since about 1998 ICPC-2: Also includes reasons for encounter (RFE), procedure codes and process of care International Classification of Sleep Disorders: NANDA: Diagnostic and Statistical Manual of Mental Disorders: Primarily psychiatric disorders
Invasive candidiasis is an infection (candidiasis) that can be caused by various species of Candida yeast. Unlike Candida infections of the mouth and throat (oral candidiasis) or vagina (Candidal vulvovaginitis), invasive candidiasis is a serious, progressive, and potentially fatal infection that can affect the blood (), heart, brain, eyes, bones, and other parts of the body.
Fungemia is the presence of fungi or yeast in the blood. The most common type, also known as candidemia, candedemia, or systemic candidiasis, is caused by Candida species. Candidemia is also among the most common bloodstream infections of any kind. [1]
Candida auris has attracted increased clinical attention because of its multiple drug resistance. [6] [7] [4]In vitro, more than 90% of C. auris isolates are resistant to fluconazole [8] [9] and a range of 3–73% of C. auris isolates are resistant to voriconazole, [9] [10] while other triazoles (posaconazole, itraconazole, and isavuconazole) display better activity.
Candidiasis is a fungal infection due to any species of the genus Candida (a yeast). [4] When it affects the mouth, in some countries it is commonly called thrush. [3] Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. [3]
Pichia kudriavzevii (formerly Candida krusei [1] [2]) is a budding yeast (a species of fungus) involved in chocolate production. P. kudriavzevii is an emerging fungal nosocomial pathogen [ 3 ] primarily found in the immunocompromised and those with hematological malignancies.
[5] [6] [7] Systemic infections of the bloodstream and major organs (candidemia or invasive candidiasis), particularly in patients with an impaired immune system (immunocompromised), affect over 90,000 people a year in the US. [8] The genome of several Candida species has been sequenced. [8]
According to the data obtained from 2010, frequency of candidemia is 12-25% in the US, 4.5-9% in Europe, 20-24% in Brazil and 20-60% in South Asia. [5] C. tropicalis can cause nosocomial fungal bloodstream infections along with C. glabrata and C. parapsilosis . [ 5 ]